Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

G. R. Ewoldt

born in Oklahoma

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 29 Apr, 2022
Paul Fuller profile picture
Paul Fuller
edited on 29 Apr, 2022
Edits made to:
Infobox (+1/-1 properties)
Infobox
Date of death
October 1991
Date of death
October 26, 1991
Paul Fuller profile picture
Paul Fuller
edited on 29 Apr, 2022
Edits made to:
Infobox (+1/-1 properties)
Infobox
Date of death
1991
Date of death
October 1991
Paul Fuller profile picture
Paul Fuller
edited on 29 Apr, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Date of death
1991
Paul Fuller profile picture
Paul Fuller
edited on 29 Apr, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Birthplace
Oklahoma
Oklahoma
Paul Fuller profile picture
Paul Fuller
edited on 29 Apr, 2022
Edits made to:
Infobox (+1/-1 properties)
Infobox
Birthdate
May 1921
Birthdate
May 6, 1921
Paul Fuller profile picture
Paul Fuller
edited on 29 Apr, 2022
Edits made to:
Infobox (+1/-1 properties)
Infobox
Birthdate
1921
Birthdate
May 1921
Paul Fuller profile picture
Paul Fuller
edited on 29 Apr, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Birthdate
1921
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI profile picture
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox (-119 properties)
Infobox
Patent primary examiner of
‌
US Patent 7122184 Specific monoclonal antibody against terbinafine
‌
US Patent 7122638 Monoclonal human natural antibodies
‌
US Patent 11173195 Immunomodulatory pharmaceutical compositions including a synthetic peptide and transforming growth factor beta
‌
US Patent 7138116 Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
‌
US Patent 7157085 Method for treating IgE-mediated disorders
‌
US Patent 7157237 Antibodies for enzymes of the ω-oxidation pathway and methods relating thereto
‌
US Patent 7169898 Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
‌
US Patent 7175990 Method of determining endometrial receptivity
‌
US Patent 7179899 Composite antibodies of humanized human subgroup IV light chain capable of binding to TAG-72
‌
US Patent 7183386 Feline immunoglobulin E proteins and compositions thereof
‌
US Patent 7183390 Humanized antibodies to gamma-interferon
‌
US Patent 7189826 Monoclonal human natural antibodies
‌
US Patent 7192583 Methods for modulating bone mineralization
‌
US Patent 7198948 Methods and compositions for obtaining mature dendritic cells
‌
US Patent 7211255 Contraceptives based on SP22 and SP22 antibodies
‌
US Patent 7214373 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
‌
US Patent 7214380 Adjuvant therapy
‌
US Patent 7214785 Human-type anti-blood coagulation factor VIII antibody
‌
US Patent 7226996 Equine Fc epsilon receptor alpha protein
‌
US Patent 7229646 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
‌
US Patent 7232898 Chimeric IgE polypeptides and host cells
‌
US Patent 7244431 Allergy vaccines and their preparation
‌
US Patent 7250168 Tissue factor targeted thrombomodulin fusion proteins as anticoagulants
‌
US Patent 7252826 Modified mite allergen and pharmaceutical uses thereof
‌
US Patent 7258858 Method of identifying high immune response animals
‌
US Patent 7262273 Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof
‌
US Patent 7264807 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
‌
US Patent 7279161 Factor IX/factor IXa activating antibodies and antibody derivatives
‌
US Patent 7285630 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor
‌
US Patent 7285650 Cloning and sequencing of the allergen Dac g5 of
‌
US Patent 7288254 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
‌
US Patent 7297336 Factor IXa specific antibodies displaying factor VIIIa like activity
‌
US Patent 7301005 Immunomodulatory peptides derived from heat shock proteins and uses thereof
‌
US Patent 7307154 DNA encoding a novel RG1 polypeptide
‌
US Patent 7309487 Methods and compositions for detecting and treating retinal diseases
‌
US Patent 7311913 Methods of treating thrombotic diseases with von Willebrand factor specific antibodies
‌
US Patent 7314856 Adrenomedullin agonists
‌
US Patent 7326769 Method for isolating and purifying grass pollen allergens
‌
US Patent 7329731 Soluble T cell receptor
‌
US Patent 7339029 Sperm-specific cation channel, CatSper2, and uses therefor
‌
US Patent 7339040 DNA molecules optimized sequences that encode the IA-2IC antigen, RNA molecules, expression vectors, transformed cells, method of preparing the IA-2IC antigen, polypeptide of the human IA-2IC antigen, and in vitro procedure and kit for the diagnosis of autoimmune diabetes
‌
US Patent 7344717 Use of erythropoietin in the treatment of rheumatoid arthritis
‌
US Patent 7348005 Oral tolerance induction by collagen to prevent allograft rejection
‌
US Patent 7355024 Regulatory sequences for modulation of INGAP expression and reporter constructs
‌
US Patent 11180559 Subcutaneous anti-HLA-DR monoclonal antibody for treatment of hematologic malignancies
‌
US Patent 7364736 Antibodies to OPGL
‌
US Patent 7365155 Immunoregulator
‌
US Patent 7365169 T-bet antibodies
‌
US Patent 7368287 Use of L-α-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro
‌
US Patent 7371385 Method of treating immune pathologies with low dose estrogen
‌
US Patent 7378089 Gene therapy for the prevention of autoimmune disease
‌
US Patent 7381790 Copolymers for suppression of autoimmune diseases, and methods of use
‌
US Patent 7390658 CD8α
‌
US Patent 7393944 T-bet compositions and methods of use thereof
‌
US Patent 7399847 Nucleic acids encoding artificial P-selectin ligands
‌
US Patent 7402313 Method for controlling preeclampsia and eclampsia
‌
US Patent 7405076 Generation and use of dendritic cells
‌
US Patent 7411051 Antibodies to HDPPA04 polypeptide
‌
US Patent 7419657 Treatment of atherosclerotic disorders
‌
US Patent 7422748 Vaccine composition of surfactants as adjuvant of immunity
‌
US Patent 7435801 Antibodies and other ligands directed against KIR2DL4 receptor for production of interferon gamma
‌
US Patent 7442547 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
‌
US Patent 7452980 Compositions and methods for the diagnosis and treatment of immune disorders
‌
US Patent 7452982 Immunogenic complex
‌
US Patent 7455984 Immunoreactive and immunotherapeutic molecules
‌
US Patent 7462486 Methods of selecting T cell receptor V peptides for therapeutic use
‌
US Patent 7465452 Tumor antigen
‌
US Patent 7479276 Antibody fragment-targeted immunoliposomes for systemic gene delivery
‌
US Patent 7488474 Method for detecting regulatory T cells using expression of folate receptor 4 as indicator, method for treating diseases using the detection method, pharmaceutical composition for immunostimulation, and method for treating diseases using the composition
‌
US Patent 7491388 Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation
‌
US Patent 7514232 Method for detecting T cell response to specific antigens in whole blood
‌
US Patent 7517527 Immunotoxin with in vivo T cell suppressant activity and methods of use
‌
US Patent 7517657 Peptides for detecting anti-double stranded DNA antibody and uses thereof
‌
US Patent 7517966 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same
‌
US Patent 7537773 Chemodenervating pharmaceutical as anti-inflammatory agent
‌
US Patent 7537900 Method for diagnosing multiple sclerosis
‌
US Patent 7547769 Immunomodulatory constructs and their uses
‌
US Patent 7550562 Pemphigus monoclonal antibody
‌
US Patent 7550569 Antibodies that specifically bind to GMAD
‌
US Patent 7553939 T cell regulatory genes and methods of use thereof
‌
US Patent 7557200 Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentation
‌
US Patent 7560104 Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentation
‌
US Patent 7560534 Molecular conjugates comprising human monoclonal antibodies to dendritic cells
‌
US Patent 7560609 Diabetic model
‌
US Patent 7563450 UL16 binding protein 4
‌
US Patent 7563866 Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses
‌
US Patent 7563876 Human monoclonal antibodies to dendritic cells
‌
US Patent 7566568 Method for generating highly active human dendritic cells from peripheral blood mononuclear cells
‌
US Patent 7566767 Synthetic peptides and methods of use for autoimmune disease therapies
‌
US Patent 7569664 Single chain recombinant T cell receptors
‌
US Patent 7572592 Method for diagnosing multiple sclerosis
‌
US Patent 7575916 Nucleic acid molecule encoding a MHC class I peptide epitope from the human 5T4 tumor-associated antigen and vector comprising the nucleic acid molecule
‌
US Patent 7579006 Method of treating immune pathologies with low dose estrogen
‌
US Patent 7595148 Methods and compositions for modulating T lymphocytes
‌
US Patent 7604811 Oral-intestinal vaccines against diseases caused by enteropathic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
‌
US Patent 7612183 Humanised anti-mag antibody or functional fragment thereof
‌
US Patent 7638329 In vitro method to generate dendritic Langerhans type cells
‌
US Patent 7658926 Autologous T-cell vaccines materials and methods
‌
US Patent 7659119 Method and compositions for obtaining mature dendritic cells
‌
US Patent 7700102 Nucleic acids encoding CD100 molecules
‌
US Patent 7718780 Preparation of monoclonal antibody to
‌
US Patent 7722871 Immunoglobulins devoid of light chains
‌
US Patent 7731964 Antibodies specific for phosphorylated insulin receptor substrate-1/2 (Ser1101/Ser1149) and uses thereof
‌
US Patent 7744876 Methods and compositions for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes
‌
US Patent 7744893 T cell receptor CDR3 sequences associated with multiple sclerosis and compositions comprising same
‌
US Patent 7744894 Method of treating multiple sclerosis and related t-cell initiated tissue destruction by administering HSA/CD24
‌
US Patent 7763251 Kits to assess the risk of tumor progression
‌
US Patent 7786047 Immunoglobulins devoid of light chains
‌
US Patent 7807377 Method of isolating antigen-specific T cells employing artificial antigen presenting cells
‌
US Patent 7815910 Vaccine composition and use of surfactants as adjuvants of immunity
‌
US Patent 7829292 Compositions and methods for diagnosing, predicting therapeutic response of, and monitoring autoimmune disease
‌
US Patent 7847069 Antibodies against SUMO4 polypeptides
‌
US Patent 7851164 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
‌
US Patent 7872098 Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies
‌
US Patent 7888115 MHC class I peptide epitopes from the human 5T4 tumor-associated antigen
‌
US Patent 7892559 Survivin-derived peptides and use thereof
‌
US Patent 7906291 Method for diagnosing multiple sclerosis
‌
US Patent 7977457 Fusion proteins, uses thereof and processes for producing same
‌
US Patent 8003331 Method for identifying target protein of drug and method for screening therapeutic agent for diabetes using the target protein
Edits on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7977457 Fusion proteins, uses thereof and processes for producing same
Edits on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7906291 Method for diagnosing multiple sclerosis
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7892559 Survivin-derived peptides and use thereof
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7888115 MHC class I peptide epitopes from the human 5T4 tumor-associated antigen
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits on 6 Dec, 2021
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7847069 Antibodies against SUMO4 polypeptides
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7815910 Vaccine composition and use of surfactants as adjuvants of immunity
Golden AI profile picture
Golden AI
edited on 5 Dec, 2021
Golden AI profile picture
Golden AI
edited on 5 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7786047 Immunoglobulins devoid of light chains

Find more people like G. R. Ewoldt

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo